Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Our aim was to detect the potential role of interleukin 11 (IL-11) in the development of chemo-resistance in gastric cancer and to reveal the mechanism involved in the process. Materials and Methods Here, we used flow cytometry to examine the percentage of cancer-associated-fibroblasts in tumor samples from chemo-resistant and -sensitive gastric cancer patients. Using MTT assay, we detected the cell viability under different conditions. Using quantitative real-time polymerase chain reaction and Western blotting, we determined the target expressions in mRNA and protein levels. We also performed immunohistochemistry and immunofluorescence to detect the target proteins under different conditions. Animal models were constructed to verify the potential role of IL-11 in chemo-resistant develop in vivo. Results Herein, we observed enriched cancer associated fibroblasts in drug resistant tumor tissues from gastric patients. Those fibroblasts facilitate the chemotherapeutic drugs resistance development through the secretion of IL-11, which activates the IL-11/IL-11R/gp130/ JAK/STAT3 anti-apoptosis signaling pathway in gastric cancer cells. We found that the combination of chemotherapeutic drugs and JAK inhibitor overcomes the resistance and increases the survival of mice with gastric cancer xenografts. Conclusion Our results demonstrated that IL-11 contributed to the obtain of resistance to chemotherapy drugs through gp130/JAK/STAT3/Bcl2 pathway, and targeting the IL-11 signaling pathway induced by fibroblasts might be a promising strategy to overcome the multi-drugs resistant cancer in clinic.
Abstract
Purpose Our aim was to detect the potential role of interleukin 11 (IL-11) in the development of chemo-resistance in gastric cancer and to reveal the mechanism involved in the process. Materials and Methods Here, we used flow cytometry to examine the percentage of cancer-associated-fibroblasts in tumor samples from chemo-resistant and -sensitive gastric cancer patients. Using MTT assay, we detected the cell viability under different conditions. Using quantitative real-time polymerase chain reaction and Western blotting, we determined the target expressions in mRNA and protein levels. We also performed immunohistochemistry and immunofluorescence to detect the target proteins under different conditions. Animal models were constructed to verify the potential role of IL-11 in chemo-resistant develop in vivo. Results Herein, we observed enriched cancer associated fibroblasts in drug resistant tumor tissues from gastric patients. Those fibroblasts facilitate the chemotherapeutic drugs resistance development through the secretion of IL-11, which activates the IL-11/IL-11R/gp130/ JAK/STAT3 anti-apoptosis signaling pathway in gastric cancer cells. We found that the combination of chemotherapeutic drugs and JAK inhibitor overcomes the resistance and increases the survival of mice with gastric cancer xenografts. Conclusion Our results demonstrated that IL-11 contributed to the obtain of resistance to chemotherapy drugs through gp130/JAK/STAT3/Bcl2 pathway, and targeting the IL-11 signaling pathway induced by fibroblasts might be a promising strategy to overcome the multi-drugs resistant cancer in clinic.
참고문헌 (34)
- Chen W, "Cancer statistics in China, 2015", CA Cancer J Clin, 66, pp.115~132 (2016)
- Holohan C, "Cancer drug resistance : an evolving paradigm", Nat Rev Cancer, 13, pp.714~726 (2013)
- Juan TY, "Antiangiogenesis targeting tumor microenvironment synergizes glucuronide prodrug antitumor activity", Clin Cancer Res, 15, pp.4600~4611 (2009)
- Quail DF, "Microenvironmental regulation of tumor progression and metastasis", Nat Med, 19, pp.1423~1437 (2013)
- Kikuchi K, "Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma", Breast Cancer Res Treat, 166, pp.709~723 (2017)
- Chua AC, "Dietary iron enhances colonic inflammation and IL-6", IL-11-Stat3 signaling promoting colonic tumor development in mice, 2013, pp.8, e78850~
- Putoczki TL, "IL-11 signaling as a therapeutic target for cancer", Immunotherapy, 7, pp.441~453 (2015)
- Tao L, "Cancerassociated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11", IL-11R, Sci Rep, pp.2016, 6[DOI]
- Johnstone CN, "Emerging roles for IL-11 signaling in cancer development and progression : focus on breast cancer", Cytokine Growth Factor Rev, 26, pp.489~498 (2015)
- Sanchez-Lopez E, "Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling", Oncogene, 35, pp.2634~2644 (2016)
- Zheng H, "TMED3 promotes hepatocellular carcinoma progression via IL-11", STAT3 signaling, 2016, pp.6, 37070~
- Hwang RF, "Cancer-associated stromal fibroblasts promote pancreatic tumor progression", Cancer Res, 68, pp.918~926 (2008)
- Johnson P, "Isolation of CD 90+ fibroblast", myofibroblasts from human frozen gastrointestinal specimens, 2016, e53691~
- Johnston A, "IL-1F5, -F6, -F8, and-F9 : a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression", J Immunol, 186, pp.2613~2622 (2011)
- Varas-Godoy M, "The crosstalk between ovarian cancer stem cell niche and the tumor microenvironment", Stem Cells Int, 2017, pp.5263974~ (2017)
- Danhier F, "To exploit the tumor microenvironment : passive and active tumor targeting of nanocarriers for anti-cancer drug delivery", J Control Release, 148, pp.135~146 (2010)
- Paraiso KH, "Fibroblast-mediated drug resistance in cancer", Biochem Pharmacol, 85, pp.1033~1041 (2013)
- Flach EH, "Fibroblasts contribute to melanoma tumor growth and drug resistance", Mol Pharm, 8, pp.2039~2049 (2011)
- Cavaco A, "Collateral damage intended-cancer-associated fibroblasts and vasculature are potential targets in cancer therapy", Int J Mol Sci, 18, pp.E2355~ (2017)
- Gal P, "How signaling molecules regulate tumor microenvironment:parallels to wound repair", Molecules, 22, pp.E1818~ (2017)
- Setrerrahmane S, "Tumor-related interleukins : old validated targets for new anti-cancer drug development", Mol Cancer, 16, pp.153~ (2017)
- Ren C, "Plasma interleukin-11(IL-11)levels have diagnostic and prognostic roles in patients with pancreatic cancer", Tumour Biol, 35, pp.11467~11472 (2014)
- De Araujo RF Jr, "Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK", Akt, FAAD proteins, pp.Int J Oncol, 2018[DOI]
- Guerriero L, "The anti-apoptotic BAG3 protein is involved in BRAF inhibitor resistance in melanoma cells", Oncotarget, 8, pp.80393~80404 (2017)
- Turner N, "Fibroblast growth factor signalling : from development to cancer", Nat Rev Cancer, 10, pp.116~129 (2010)
- Sun Y, "Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B", Nat Med, 18, pp.1359~1368 (2012)
- Straussman R, "Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion", Nature, 487, pp.500~504 (2012)
- Baudino TA, "Targeted cancer therapy : the next generation of cancer treatment", Curr Drug Discov Technol, 12, pp.3~20 (2015)
- Coley HM, "Overcoming multidrug resistance in cancer : clinical studies of p-glycoprotein inhibitors", Methods Mol Biol, 596, pp.341~358 (2010)
- Zhu W, "Supramolecular hydrogels as a universal scaffold for stepwise delivering Dox and Dox", cisplatin loaded block copolymer micelles, 2012, pp.437, 11~19
- Meads MB, "Environment-mediated drug resistance : a major contributor to minimal residual disease", Nat Rev Cancer, 9, pp.665~674 (2009)
- Yu Y, "Cancerassociated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling", Br J Cancer, 110, pp.724~732 (2014)
- Nakayama T, "Expression of interleukin-11(IL-11)and IL-11 receptor alpha in human gastric carcinoma and IL-11upregulates the invasive activity of human gastric carcinoma cells", Int J Oncol, 30, pp.825~833 (2007)
- Ernst M, "STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice", J Clin Invest, 118, pp.1727~1738 (2008)